(NASDAQ: WVE) Wave Life Sciences's forecast annual revenue growth rate of 2.03% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.16%.
Wave Life Sciences's revenue in 2026 is $65,371,000.On average, 20 Wall Street analysts forecast WVE's revenue for 2026 to be $9,966,302,595, with the lowest WVE revenue forecast at $7,376,695,479, and the highest WVE revenue forecast at $17,172,748,451. On average, 20 Wall Street analysts forecast WVE's revenue for 2027 to be $8,823,029,084, with the lowest WVE revenue forecast at $0, and the highest WVE revenue forecast at $27,724,678,223.
In 2028, WVE is forecast to generate $15,014,479,790 in revenue, with the lowest revenue forecast at $540,700,192 and the highest revenue forecast at $83,174,034,668.